학술논문
Updated Dose Expansion Results of a Phase 1/1b Study of the Bifunctional EGFR/TGFβ Inhibitor BCA101 with Pembrolizumab in Patients with Recurrent, Metastatic Head and Neck Squamous Cell Carcinoma
Document Type
Abstract
Author
Source
In International Journal of Radiation Oncology, Biology, Physics 1 April 2024 118(5):e88-e88
Subject
Language
ISSN
0360-3016